SCAI is embarking on a new strategic planning process. Its goal is to determine the course SCAI should take over the next 3-5 years, and to position SCAI, its members and their patients for continued success in coming decades. Put simply, we are aiming for both long-and short-term success. During the past several months SCAI leaders and staff have sought input from members, other societies, industry partners and patients.
MISSION, VISION, CORE VALUES

SCAI's Strategic Planning Working Group and
Board of Trustees will refine our current mission statement (what SCAI is all about), develop a vision statement (where we want SCAI to go) and define SCAI's core values (guiding principles for engaging internal and external stakeholders).
Before we begin a new plan, we should assess how well SCAI's last strategic plan worked. Strategic planning manuals say that many strategic plans only gather dust on a shelf. Did that happen with ours?
SCAI's most recent strategic plan was crafted by a large group of respected SCAI leaders in 2005. In reviewing it, one is struck by the wisdom of its authors and SCAI's success in achieving the goals it set. The 2005 strategic plan identified 7 "most critical" strategic initiatives and 6 "other strategic initiatives". Most of the 7 critical goals and 6 other strategic goals have been accomplished, as discussed below and demonstrated in the Table. 2005 "MOST CRITICAL" STRATEGIC INITIATIVES clinical trial submissions, participation by exhibitors, and media coverage have increased. A specific goal, to establish a durable organizational structure for planning the meeting, was also accomplished: in recent years the Program Committee has been re-organized, with planned succession of committee members to the cochair role over several years. 3. Augment the SCAI website with new features; enhance online services. Since the mid-2000s, we have greatly expanded SCAI's online presence and with it opportunities for SCAI members to engage. SCAI.org now houses clinical content submissions from members, including image reviews, journal scans and journal clubs. SCAI has become a leader in mobile app development for the cardiovascular field with, for example, the SCAI-Quality Improvement PCI Risk and AUC calculator apps. The SCAI-QIT AUC calculator app is now used routinely by many cardiac cath labs.
4. Construct business models for developing SCAIsponsored data registries. Since 2005, SCAI has collaborated on the development of four registries:
The CARE (Carotid Artery Revascularization and Endarterectomy) Registry, focused on carotid stenting or carotid endarterectomy for the purpose of stroke prevention; The IMPACT (IMproving Pediatric and Adult Congenital Treatment) Registry, focused on diagnostic catheterization and catheter-based interventions for congenital heart disease in both the adult and pediatric population;
The WIN TAVI Registry, sponsored by SCAI's Women in Innovation (WIN) initiative, dedicated to data collection on female patients undergoing transcatheter aortic valve implantation for the purpose of treating severe aortic stenosis; and The TVT Registry, focused on patients undergoing transcatheter aortic valve implantation for the purpose of treating severe aortic stenosis.
5. Develop a process for accreditation to perform carotid artery stenting (CAS). SCAI collaborated with other societies to publish a consensus statement on clinical competence requirements for CAS [1] . SCAI also created a CAS facility accreditation program, termed "SCAI-CAP" (SCAI Carotid Accreditation Program) [2] . Subsequently, SCAI and the American College of Cardiology created Accreditation for Cardiovascular Excellence (ACE), which currently offers accreditation for CAS facilities [3] . In 2005, it was expected that the Centers for Medicare and Medicaid Services (CMS) would mandate accreditation for CAS facilities, but CMS instead allowed selfaccreditation by facilities that perform CAS [4] .
6. Adopt a proactive structured approach to educational programming. Since 2005, SCAI has revised its approach for providing educational opportunities for interventional cardiologists and cath lab professionals. The result has been a diversified educational portfolio that includes the flagship Scientific Sessions and Fellows Courses; regional programs focused on key clinical areas such as transradial interventions, treatment of chronic total occlusions, and peripheral vascular disease; and a range of online programs. SCAI's Education Committee developed processes that tap the expertise of the Society's many committees and assess the needs of practicing physicians, nurses, technologists and cath lab administrators. SCAI's Cath Lab Leadership Boot Camp is a direct result of the Education Committee's success in providing innovative programming.
7. Establish SCAI as the premier organization for interventional cardiologists specializing in congenital heart disease (CHD). In 2009, the CHD Council was formed to further education, advocacy and information exchange within the pediatric interventionist community. Today, the CHD Council has increased its reach with an active list-serve of more than 400 pediatric interventionists and their cath lab teams. The CHD Executive Committee oversees all congenital priorities, including publishing clinical documents, advancing the IMPACT Registry, developing training standards, advocating for safe and effective medical devices, and advancing quality through the Pediatric SCAI-Quality Improvement Toolkit. SCAI's Pediatric Interventional Cardiology Early Career (PICES) Committee is dedicated to the professional development of early-career physicians. 
